Brief: Diasorin Q1 Adj. EBITDA EUR 90 Mln
May 8 (Reuters) - DiaSorin SpA DIAS.MI: CONFIRMS 2026 GUIDANCE Q1 ADJUSTED EBITDA EUR 90 MILLION Q1 REVENUE EUR 287 MILLION Q1 NET PROFIT EUR 38 MILLION Further company coverage: DIAS.MI (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21